#VisualAbstract: A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
1. A randomized control trial of patients with multidrug resistant tuberculosis found that shorter treatment regimens were noninferior to longer ...
1. A randomized control trial of patients with multidrug resistant tuberculosis found that shorter treatment regimens were noninferior to longer ...
1. A randomized control trial of patients with multidrug resistant tuberculosis found that shorter treatment regimens were noninferior to longer ...
1. Children with tuberculosis (TB) who received 3 months of directly observed preventative therapy (DOPT) were >25 times more likely ...
1. Once-weekly isoniazid (INH) and rifapentine treatment for latent tuberculosis infection (LTBI) via self-administered therapy (SAT) had high completion rates ...
1. Results of a meta-analysis confirm evidence of efficacy and safety of 6-month isoniazid monotherapy and rifampicin monotherapy for latent ...
1. This randomized controlled trial of a urine-based point-of-care lipoarabinomannan assay (LAM) to detect tuberculosis infection in HIV-positive patients resulted ...
1. Intensified antituberculosis treatment was not associated with a higher rate of survival among patients with tuberculous (TB) meningitis than ...
1. A systematic review and meta-analysis of studies comparing the Xpert MTB/RIF assay to smear microscopy for the diagnosis of ...
1. From a cross-sectional study, the implementation of a new culture-based tuberculosis (TB) screening algorithm for immigrants was associated with ...
1. Tuberculosis (TB) granulomas exhibited similar properties to solid cancerous tumors, characterized as dense tissue masses with abnormal blood vessel ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.